Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.

Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.

Item
http://www.wikidata.org/entity/Q37204267
Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children.Pharmacokinetics and virological efficacy after switch to once-daily lopinavir-ritonavir in treatment-experienced HIV-1-infected childrenPharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children.It is time to consider third-line options in antiretroviral-experienced paediatric patients?Assessment of lopinavir pharmacokinetics with respect to developmental changes in infants and the impact on weight band-based dosing.Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children.Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.The role of formulation on the pharmacokinetics of antiretroviral drugs.Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV.Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children.
P2860

Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.

Item
http://www.wikidata.org/entity/Q37204267
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population pharmacokinetics of ...... iency virus-infected children.
@en
Population pharmacokinetics of ...... iency virus-infected children.
@nl
type
label
Population pharmacokinetics of ...... iency virus-infected children.
@en
Population pharmacokinetics of ...... iency virus-infected children.
@nl
prefLabel
Population pharmacokinetics of ...... iency virus-infected children.
@en
Population pharmacokinetics of ...... iency virus-infected children.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Population pharmacokinetics of ...... iency virus-infected children.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932